{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:50:38Z","timestamp":1770331838050,"version":"3.49.0"},"reference-count":36,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1010.040362","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T19:44:56Z","timestamp":1332963896000},"page":"1760-1765","source":"Crossref","is-referenced-by-count":47,"title":["Sulfa Use, Dihydropteroate Synthase Mutations, and<i>Pneumocystis jirovecii<\/i>Pneumonia"],"prefix":"10.3201","volume":"10","author":[{"given":"Cheryl R.","family":"Stein","sequence":"first","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Poole","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Powel","family":"Kazanjian","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Meshnick","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2004,10]]},"reference":[{"key":"key-10.3201\/eid1010.040362-201203280400-R1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1086\/344951","article-title":"Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome.","volume":"36","author":"Fisk","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1010.040362-201203280400-R2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1010.040362-201203280400-R3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus\u2013associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1010.040362-201203280400-R4","unstructured":"Cohn DL, Breese PS, Burman WJ, Lopez DL, Barth BL, Rietmeijer CA, Continued benefit from highly active antiretroviral therapy: trends in AIDS-related opportunistic illnesses in a public health care system, 1990\u20132001. XIV International AIDS Conference. Barcelona, Spain, 2002. Abstract no. ThOrC1443. Available from http:\/\/www.ias.se\/abstract\/show.asp?abstract_id=4991"},{"key":"key-10.3201\/eid1010.040362-201203280400-R5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"key-10.3201\/eid1010.040362-201203280400-R6","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"key-10.3201\/eid1010.040362-201203280400-R7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00126334-200209010-00003","article-title":"Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy.","volume":"31","author":"Bennett","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.3201\/eid1010.040362-201203280400-R8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00002030-200403260-00008","article-title":"Long-term safety and durable antiretroviral activity of lopinavir\/ritonavir in treatment-naive patients: 4 year follow-up study.","volume":"18","author":"Hicks","year":"2004","journal-title":"AIDS"},{"key":"key-10.3201\/eid1010.040362-201203280400-R9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/00126334-200406010-00007","article-title":"Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.","volume":"36","author":"Garcia","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.3201\/eid1010.040362-201203280400-R10","unstructured":"The WHO and UNAIDS global initiative to provide antiretroviral therapy to 3 million people with HIV\/AIDS in developing countries by the end of 2005. Geneva: World Health Organization; 2003."},{"key":"key-10.3201\/eid1010.040362-201203280400-R11","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.36.9.1935","article-title":"Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia.","volume":"36","author":"Walzer","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1010.040362-201203280400-R12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jac\/36.1.137","article-title":"The SCID mouse as an experimental model for the evaluation of anti-Pneumocystis carinii therapy.","volume":"36","author":"Kunz","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1010.040362-201203280400-R13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1089\/apc.1998.12.843","article-title":"Failure of prophylaxis against PCP in patients with HIV infection.","volume":"12","author":"Bonora","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"key-10.3201\/eid1010.040362-201203280400-R14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00042560-199810010-00013","article-title":"Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) investigators.","volume":"19","author":"Moorman","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key-10.3201\/eid1010.040362-201203280400-R15","unstructured":"Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott Williams and Wilkins; 1998."},{"key":"key-10.3201\/eid1010.040362-201203280400-R16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat.","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"key-10.3201\/eid1010.040362-201203280400-R17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00001648-200105000-00005","article-title":"Low P-values or narrow confidence intervals: which are more durable?","volume":"12","author":"Poole","year":"2001","journal-title":"Epidemiology"},{"key":"key-10.3201\/eid1010.040362-201203280400-R18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"key-10.3201\/eid1010.040362-201203280400-R19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"key-10.3201\/eid1010.040362-201203280400-R20","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods.","volume":"18","author":"Thompson","year":"1999","journal-title":"Stat Med"},{"key":"key-10.3201\/eid1010.040362-201203280400-R21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/00002030-199808000-00009","article-title":"Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.","volume":"12","author":"Kazanjian","year":"1998","journal-title":"AIDS"},{"key":"key-10.3201\/eid1010.040362-201203280400-R22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(99)03320-6","article-title":"Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.","volume":"354","author":"Helweg-Larsen","year":"1999","journal-title":"Lancet"},{"key":"key-10.3201\/eid1010.040362-201203280400-R23","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1086\/315148","article-title":"Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.","volume":"180","author":"Ma","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040362-201203280400-R24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1086\/315824","article-title":"Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene.","volume":"182","author":"Huang","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040362-201203280400-R25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1086\/315719","article-title":"Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.","volume":"182","author":"Kazanjian","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040362-201203280400-R26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0924-8579(01)00460-5","article-title":"Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.","volume":"18","author":"Visconti","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid1010.040362-201203280400-R27","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1086\/340220","article-title":"Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.","volume":"185","author":"Ma","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040362-201203280400-R28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0924-8579(03)00122-5","article-title":"Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveii isolates from Portuguese patients with Pneumocystis pneumonia.","volume":"22","author":"Costa","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid1010.040362-201203280400-R29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1550-7408.2003.tb00648.x","article-title":"Pneumocystis dihydropteroate synthase mutations in patients with Pneumocystis pneumonia who are newly diagnosed with HIV infection.","volume":"50","author":"Crothers","year":"2003","journal-title":"J Eukaryot Microbiol"},{"key":"key-10.3201\/eid1010.040362-201203280400-R30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/13693780310001615394","article-title":"Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998-2001 prospective study.","volume":"41","author":"Latouche","year":"2003","journal-title":"Med Mycol"},{"key":"key-10.3201\/eid1010.040362-201203280400-R31","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1128\/AAC.47.12.3979-3981.2003","article-title":"Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.","volume":"47","author":"Miller","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1010.040362-201203280400-R32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1086\/378239","article-title":"Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine\/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.","volume":"188","author":"Nahimana","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040362-201203280400-R33","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1128\/JCM.41.6.2709-2712.2003","article-title":"Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjects.","volume":"41","author":"Zingale","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1010.040362-201203280400-R34","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/JCM.38.9.3161-3164.2000","article-title":"Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.","volume":"38","author":"Takahashi","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1010.040362-201203280400-R35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(01)05705-1","article-title":"Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study.","volume":"358","author":"Navin","year":"2001","journal-title":"Lancet"},{"key":"key-10.3201\/eid1010.040362-201203280400-R36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/oxfordjournals.aje.a010035","article-title":"Random-effects meta-analyses are not always conservative.","volume":"150","author":"Poole","year":"1999","journal-title":"Am J Epidemiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/10\/10\/04-0362_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:51:03Z","timestamp":1732589463000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/10\/10\/04-0362_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2004,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1010.040362","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}